0001161697-24-000024.txt : 20240103 0001161697-24-000024.hdr.sgml : 20240103 20240103171853 ACCESSION NUMBER: 0001161697-24-000024 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240101 FILED AS OF DATE: 20240103 DATE AS OF CHANGE: 20240103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Daly Richard J CENTRAL INDEX KEY: 0001635393 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33057 FILM NUMBER: 24508175 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 1500 CITY: CORAL GABLES STATE: FL ZIP: 33134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001369568 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: (305) 529-2522 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC. DATE OF NAME CHANGE: 20110215 FORMER COMPANY: FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc. DATE OF NAME CHANGE: 20060719 4 1 form4.xml FORM 4 FOR 01-01-2024 X0508 4 2024-01-01 0 0001369568 CATALYST PHARMACEUTICALS, INC. CPRX 0001635393 Daly Richard J 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 1 1 0 0 President and CEO 0 Options to purchase common stock 13.30 2024-01-01 4 A 0 1365319 0 A 2031-01-01 Common Stock 1365319 1564486 D Restricted Stock Units 2024-01-01 4 A 0 210526 0 A Common Stock 210526 1775012 D Price of derivative security is based upon the date on which the Reporting Person's executed their offer letter (dated October 18, 2023) with the Registrant, in accordance with the Registrant's 2018 Stock Incentive Plan. Mr. Daly became the Registrant's President and Chief Executive Officer on January 1, 2024 and remains a member of the Registrant's Board of Directors. Derivative securities vest in five equal annual tranches beginning on January 1, 2025. Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting. Shares of common stock will be delivered to the Reporting Person upon vesting. /s/ Richard J. Daly 2024-01-03